Determination of Gliquidone in Human Plasma by LC-MS/MS and Bioequivalence Study of Its Two Tablets

Liu Hui‐chen

2013-01-01

Abstract:Objective:To develop a liquid chromatographic-mass spectrometric(LC-MS/MS)method for the determination of gliquidone in human plasma and evaluate the bioequivalence of its two tablets.Methods:In a randomized,double-period,self-crossover study,22 healthy male subjects received a single oral dose of test or reference formulation containing 30 mg gliquidone.Gliquidone in plasma was determined by the LC-MS/MS method after precipitation of protein.The main pharmacokinetic parameters were calculated by software DAS 2.1.1.and the bioequivalence of two formulations was evaluated.Results:The linear calibration curve was obtained over the concentration range of 10.0-1000 ng·mL-1.The intra-and inter-batch relative standard deviation(RSD)were both less than 15% and the relative error(RE)was within±15%.The main pharmacokinetic parameters of test formulation and reference formulation were as following:AUC0-t were(2717.0±685.6)and(2719.7±744.2)ng·h·mL-1;Cmax were(510±202)and(514±185)ng·mL-1;Tmax were(3.5±1.0)and(3.7±1.1)h;t1/2 were(5.9±5.5)and(6.9±6.4)h,respectively.By calculation of AUC0-t,the relative bioavailability of test formulation was(102.1±18.3)%.Conclusion: The method was simple,sensitive,specific and suitable for the bioequivalence study of gliquidone oral formulations in human.The statistic data showed that the test formulation and reference formulation had the similar rate and extent of absorption,and they were bioequivalent.